How Connecticut’s Healthcare System Makes Money While Patients Pay More

Connecticut’s lawmakers are quietly pushing big changes to a federal drug discount program that feels more like a business deal than public policy. A last-minute addition to a routine bill quietly expanded the 340B program, letting hospitals buy drugs at extreme discounts—sometimes for a fraction of their normal cost—and charge patients or insurance companies full price. The difference doesn’t go to help patients; it goes straight to the hospital’s bottom line. And this isn’t a small side note—it’s happening at scale. Roughly two-thirds of pharmacies handling these discounted drugs aren’t even in the areas they’re supposed to serve, often in wealthy or even out-of-state locations.The program was originally created to help low-income and uninsured patients afford medicine, but today it’s being used to boost hospital profits instead. Hospitals can qualify for more discounts by increasing their share of low-income patients, sometimes through creative loopholes that bypass normal oversight. During a public hearing, a UConn Health representative admitted—under oath—that these savings rarely reach patients. Even worse, lawmakers tried to introduce bills that would have forced hospitals to pass on the discounts, but those ideas never made it to a vote. This isn’t just an oversight. It’s a system built to make money disappear from patients and reappear in hospital budgets. Connecticut businesses already pay an extra $121 million each year because insurers and patients aren’t getting the discounts they were promised. That money doesn’t vanish—it gets added to everyone’s healthcare bills, making care even more expensive for families. The 340B program doesn’t have to fail. It can still help the people it was designed for—but only if lawmakers actually enforce the rules instead of expanding them behind closed doors.